Genomtec S.A. Logo

Genomtec S.A.

GMT | WAR

Overview

Corporate Details

ISIN(s):
PLGNMTC00017
LEI:
259400ND13Y44ADMG554
Country:
Poland
Address:
WROCŁAW BIERUTOWSKA 57-59, 51-317 WROCŁAW
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genomtec S.A. is a medical technology company specializing in the research, development, and commercialization of innovative molecular diagnostic solutions. The company's flagship product is the Genomtec ID, a mobile platform designed for rapid and precise genetic diagnostics at the point-of-care. Its core technology is based on proprietary isothermal nucleic acid amplification methods. A key commercialized product is the CE-IVD certified GenomtecID Respiratory Panel 5-Plex, which detects viruses and bacteria responsible for respiratory tract infections. The company is also advancing its OncoSNAAT project in the field of genomics.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Genomtec S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 17:28
Share Issue/Capital Change
Przyznanie akcji w ramach warunkowego podwyższenia kapitału zakładowego - Conte…
Polish 2.2 KB
2025-08-01 15:26
Regulatory News Service
Otrzymanie od Urzędu Patentowego w Japonii decyzji o udzieleniu ochrony patento…
Polish 1.7 KB
2025-07-31 10:13
Board/Management Information
Powołanie nowego Członka Zarządu GENOMTEC S.A. - Content (PL)
Polish 2.7 KB
2025-07-11 20:04
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
Polish 1.0 KB
2025-07-11 20:00
Post-Annual General Meeting Information
zal01_GENOMTEC_ESPI_32_2025_Zalacznik..pdf
Polish 129.4 KB
2025-07-11 20:00
Post-Annual General Meeting Information
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Genomtec S.A. w dn…
Polish 627 bytes
2025-06-13 18:00
Post-Annual General Meeting Information
zal02_2._Projekty_uchwal_NWZ_13.06.2025.pdf
Polish 144.5 KB
2025-06-13 18:00
Pre-Annual General Meeting Information
zal01_1._Ogloszenie_o_zwolaniu_NWZ.pdf
Polish 185.9 KB
2025-06-13 18:00
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Genomtec S.A. na dzień 11 lipca 20…
Polish 1.6 KB
2025-06-06 07:21
Post-Annual General Meeting Information
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 1.7 KB
2025-06-06 07:18
Post-Annual General Meeting Information
zal01_GENOMTEC_ESPI_29_2025_Uchway_ZWZ_Zalacznik..pdf
Polish 550.6 KB
2025-06-06 07:18
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie Genomtec S.A. …
Polish 625 bytes
2025-05-29 17:25
Quarterly Report
zal02_Pozostale_informacje_do_raportu_za_1Q2025.pdf
Polish 842.1 KB
2025-05-29 17:25
Quarterly Report
zal01_spr_I_Q_2025.pdf
Polish 166.4 KB
2025-05-23 15:12
Remuneration Information
zal01_GENOMTEC_UA2024_Raport_z_wykonanej_uslugi_ost.pdf
Polish 391.8 KB

Automate Your Workflow. Get a real-time feed of all Genomtec S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genomtec S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Global pharmaceutical company creating innovative treatments for brain diseases.
Denmark HLUN
Hong Kong N/A
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL
Idorsia Ltd Logo
Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.
Switzerland IDIA
Immuno-Biological Laboratories Co., Ltd. Logo Japan 4570
Indivior PLC Logo
A global pharmaceutical firm developing treatments for addiction and mental illness.
United Kingdom INDV
Infant Bacterial Therapeutics Logo
Developing microbiome therapies for premature infants to prevent life-threatening intestinal disease.
Sweden IBT
Intercure Ltd. Logo
Producer of pharma-grade, GMP-certified medical cannabis products for patients outside North America.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines for animal health, led by its vaccine for equine strangles.
Sweden IVACC
Ipsen Logo
Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN